News
最新消息
2025年日本Daicel Accelerator 日本國際企業加速器 2025 年度大獎得獎團隊公告 Announcement of the Winning Team of Daicel Accelerator 2025
2025.11.03
2025.11.03
Daicel Accelerator 2025 年度大獎得獎團隊：奇翼醫電 (Singular Wings Medical)
DAICEL 企業加速器 (Daicel Accelerator) 是由日本百年企業 DAICEL 集團與工業技術研究院 (ITRI) 攜手合作，在台灣啟動的跨國合作加速器計畫，2025年邁入第2屆引領台灣新創圈對接日本及國際市場的徵案盛事。本計畫旨在深化國際大企業與台灣新創及中小企業的合作夥伴關係 (Corporate Startup Engagement, CSE)，共同推動產業創新與國際合作。
圖1. 參與 DAICEL Accelerator 2025 Final Pitch 之團隊
經過為期數月的徵案、篩選、訪談、可行場域驗證評估，Daicel 集團選出8家有機會與Daicel PoC合作的入圍新創，並於10/28舉辦的決選，我們很高興地宣布，2025 年度 Daicel Accelerator Final Pitch 的最高榮譽 Grand Prize 獎金一百萬日圓 (¥1,000,000 JPY) ，由奇翼醫電 (Singular Wings Medical) 獲得！
圖2. 由Daicel Group 頒發 Daicel Accelerator 2025年度大獎予得獎團隊奇翼醫電
奇翼醫電 (Singular Wings Medical) 成功在眾多優秀團隊中脫穎而出，以其在智慧醫療技術 (smart medtech) 與非接觸式感測人體生理資訊 (non-invasive vital sensing) 領域的創新解決方案，完美契合 Daicel 集團的策略發展方向 。奇翼醫電展現了台灣新創技術與百年企業資源結合的巨大潛力，成為 Daicel Accelerator 促進台日產業 CSE 合作的又一示範案例。
企業加速器是大型企業與新創公司進行系統化合作的開放式創新模式 (Open Innovation) ，我們樂見 Daicel Accelerator 率先日本企業對接台灣新創的策略模式成功發揮企業新創鏈結 (CSE) 示範效果。奇翼醫電作為年度大獎得主，將獲得與 Daicel 集團更深度的概念驗證 (PoC) 合作、通路拓展、以及共同研發等全方位支持 。
Daicel Accelerator 將持續歡迎台灣及海外各大企業、新創與中小企業的交流與互動！請持續關注 2026 年 Daicel Accelerator Program 相關報名資訊。
Daicel Accelerator 2025 Grand Prize Winner: Singular Wings Medical
The DAICEL Accelerator, a cross-border collaboration program, was established by the century-old Japanese corporation DAICEL Group and Taiwan's Industrial Technology Research Institute (ITRI). In 2025, it successfully entered its second year, leading the charge for Taiwanese startups to engage with the Japanese and international markets. The program is designed to deepen Corporate Startup Engagement (CSE) partnerships between large international corporations and Taiwanese startups/SMEs, jointly fostering industrial innovation and international cooperation.
Figure 1: Teams participating in the Daicel Accelerator 2025 Final Pitch
After a rigorous process spanning several months, including open calls, screening, interviews, feasibility PoC evaluations, and the Final Pitch on 10/28 with 8 finalists with high PoC potentials, we are thrilled to announce that the winner of the Daicel Accelerator 2025 Grand Prize, which includes a cash award of 1,000,000 JPY (¥1,000,000), is Singular Wings Medical!
Figure 2: Daicel Group presenting the Daicel Accelerator 2025 Grand Prize to Singular Wings Medical
Singular Wings Medical successfully stood out among numerous excellent teams. Its innovative solutions in smart medtech and non-invasive vital sensing perfectly align with the strategic development areas of the Daicel Group. Singular Wings Medical demonstrates the immense potential of combining Taiwanese startup technology with the resources of a century-old corporation, thereby becoming another exemplary case of Daicel Accelerator's success in promoting Taiwan-Japan CSE collaboration.
Corporate accelerators represent an Open Innovation model for systematic collaboration between large enterprises and startups. We are proud that the Daicel Accelerator, pioneering a strategic approach for a Japanese corporation to engage with Taiwanese startups, has successfully demonstrated the powerful effect of Corporate Startup Engagement (CSE). As the Grand Prize winner, Singular Wings Medical will receive comprehensive support, including deeper Proof of Concept (PoC) collaboration, channel expansion, and joint R&D with the Daicel Group.
Daicel Accelerator continues to welcome engagement and interaction from corporations, startups, and SMEs in Taiwan and abroad! Please stay tuned for the application details regarding the Daicel Accelerator Program 2026.